The CONSORT statement for cluster randomised trials

Marion Kay Campbell, Diana R. Elbourne, Douglas G. Altman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

With the publication of the CONSORT statement there is now increased awareness of the need to adequately report the findings of randomised controlled trials. The CONSORT statement includes a checklist of items that should be addressed in the trial report. The original CONSORT statement was developed to ensure the appropriate reporting of parallel group randomised controlled trials in which individual participants are allocated to different intervention groups. In cluster randomised trials, however, groups of participants, rather than individuals, are randomly allocated to study groups. The process of allocating groups of participants raises additional reporting considerations and led to the publication of an extension to the CONSORT statement specifically for cluster randomised trials. In this paper we review the CONSORT extension to cluster randomised trials, outlining the special features of the cluster randomised trial which must be considered.

Original languageEnglish
Pages (from-to)28-31
Number of pages4
JournalMedicina Clínica
Volume125
Issue numberSuppl. 1
Publication statusPublished - 2005

Keywords

  • randomised controlled trials
  • reporting standards
  • CONSORT
  • cluster randomisation
  • group allocation
  • reporting checklist

Cite this

Campbell, M. K., Elbourne, D. R., & Altman, D. G. (2005). The CONSORT statement for cluster randomised trials. Medicina Clínica, 125(Suppl. 1), 28-31.

The CONSORT statement for cluster randomised trials. / Campbell, Marion Kay; Elbourne, Diana R.; Altman, Douglas G.

In: Medicina Clínica, Vol. 125, No. Suppl. 1, 2005, p. 28-31.

Research output: Contribution to journalArticle

Campbell, MK, Elbourne, DR & Altman, DG 2005, 'The CONSORT statement for cluster randomised trials', Medicina Clínica, vol. 125, no. Suppl. 1, pp. 28-31.
Campbell MK, Elbourne DR, Altman DG. The CONSORT statement for cluster randomised trials. Medicina Clínica. 2005;125(Suppl. 1):28-31.
Campbell, Marion Kay ; Elbourne, Diana R. ; Altman, Douglas G. / The CONSORT statement for cluster randomised trials. In: Medicina Clínica. 2005 ; Vol. 125, No. Suppl. 1. pp. 28-31.
@article{bc6f36bb63f94e2cb2e3da1f36196c62,
title = "The CONSORT statement for cluster randomised trials",
abstract = "With the publication of the CONSORT statement there is now increased awareness of the need to adequately report the findings of randomised controlled trials. The CONSORT statement includes a checklist of items that should be addressed in the trial report. The original CONSORT statement was developed to ensure the appropriate reporting of parallel group randomised controlled trials in which individual participants are allocated to different intervention groups. In cluster randomised trials, however, groups of participants, rather than individuals, are randomly allocated to study groups. The process of allocating groups of participants raises additional reporting considerations and led to the publication of an extension to the CONSORT statement specifically for cluster randomised trials. In this paper we review the CONSORT extension to cluster randomised trials, outlining the special features of the cluster randomised trial which must be considered.",
keywords = "randomised controlled trials, reporting standards, CONSORT, cluster randomisation, group allocation, reporting checklist",
author = "Campbell, {Marion Kay} and Elbourne, {Diana R.} and Altman, {Douglas G.}",
note = "Full text PDF in Spanish only",
year = "2005",
language = "English",
volume = "125",
pages = "28--31",
journal = "Medicina Cl{\'i}nica",
issn = "0025-7753",
publisher = "Ediciones Doyma, S.L.",
number = "Suppl. 1",

}

TY - JOUR

T1 - The CONSORT statement for cluster randomised trials

AU - Campbell, Marion Kay

AU - Elbourne, Diana R.

AU - Altman, Douglas G.

N1 - Full text PDF in Spanish only

PY - 2005

Y1 - 2005

N2 - With the publication of the CONSORT statement there is now increased awareness of the need to adequately report the findings of randomised controlled trials. The CONSORT statement includes a checklist of items that should be addressed in the trial report. The original CONSORT statement was developed to ensure the appropriate reporting of parallel group randomised controlled trials in which individual participants are allocated to different intervention groups. In cluster randomised trials, however, groups of participants, rather than individuals, are randomly allocated to study groups. The process of allocating groups of participants raises additional reporting considerations and led to the publication of an extension to the CONSORT statement specifically for cluster randomised trials. In this paper we review the CONSORT extension to cluster randomised trials, outlining the special features of the cluster randomised trial which must be considered.

AB - With the publication of the CONSORT statement there is now increased awareness of the need to adequately report the findings of randomised controlled trials. The CONSORT statement includes a checklist of items that should be addressed in the trial report. The original CONSORT statement was developed to ensure the appropriate reporting of parallel group randomised controlled trials in which individual participants are allocated to different intervention groups. In cluster randomised trials, however, groups of participants, rather than individuals, are randomly allocated to study groups. The process of allocating groups of participants raises additional reporting considerations and led to the publication of an extension to the CONSORT statement specifically for cluster randomised trials. In this paper we review the CONSORT extension to cluster randomised trials, outlining the special features of the cluster randomised trial which must be considered.

KW - randomised controlled trials

KW - reporting standards

KW - CONSORT

KW - cluster randomisation

KW - group allocation

KW - reporting checklist

M3 - Article

VL - 125

SP - 28

EP - 31

JO - Medicina Clínica

JF - Medicina Clínica

SN - 0025-7753

IS - Suppl. 1

ER -